Current Ratio in % of ELITE PHARMACEUTICALS INC /NV/ from Q4 2011 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Current Ratio history and change rate from Q4 2011 to Q3 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Current Ratio for the quarter ending 30 Sep 2025 was 562 %, a 100% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 562 +281 +100% 30 Sep 2025
Q2 2025 457 +219 +92.3% 30 Jun 2025
Q1 2025 364 +144 +65.4% 31 Mar 2025
Q4 2024 323 +115 +55.5% 31 Dec 2024
Q3 2024 280 +24.4 +9.51% 30 Sep 2024
Q2 2024 237 -99.6 -29.5% 30 Jun 2024
Q1 2024 220 -192 -46.6% 31 Mar 2024
Q4 2023 208 -212 -50.4% 31 Dec 2023
Q3 2023 256 -116 -31.3% 30 Sep 2023
Q2 2023 337 +13.1 +4.03% 30 Jun 2023
Q1 2023 412 +149 +56.6% 31 Mar 2023
Q4 2022 419 +174 +70.8% 31 Dec 2022
Q3 2022 372 +151 +68.1% 30 Sep 2022
Q2 2022 324 +118 +57.3% 30 Jun 2022
Q1 2022 263 +77.5 +41.8% 31 Mar 2022
Q4 2021 246 +82.8 +50.9% 31 Dec 2021
Q3 2021 222 +78.5 +54.9% 30 Sep 2021
Q2 2021 206 +79.7 +63.1% 30 Jun 2021
Q1 2021 186 +70.2 +60.9% 31 Mar 2021
Q4 2020 163 +45.4 +38.7% 31 Dec 2020
Q3 2020 143 +21 +17.2% 30 Sep 2020
Q2 2020 126 -12.4 -8.91% 30 Jun 2020
Q1 2020 115 -52.7 -31.4% 31 Mar 2020
Q4 2019 117 -86.2 -42.3% 31 Dec 2019
Q3 2019 122 -131 -51.7% 30 Sep 2019
Q2 2019 139 -161 -53.8% 30 Jun 2019
Q1 2019 168 -182 -52% 31 Mar 2019
Q4 2018 204 -218 -51.7% 31 Dec 2018
Q3 2018 253 -209 -45.2% 30 Sep 2018
Q2 2018 300 -151 -33.4% 30 Jun 2018
Q1 2018 350 -87.6 -20% 31 Mar 2018
Q4 2017 421 +23 +5.78% 31 Dec 2017
Q3 2017 461 +119 +34.8% 30 Sep 2017
Q2 2017 451 +143 +46.4% 30 Jun 2017
Q1 2017 437 +140 +47.3% 31 Mar 2017
Q4 2016 398 +129 +48% 31 Dec 2016
Q3 2016 342 +55.1 +19.2% 30 Sep 2016
Q2 2016 308 +6.46 +2.14% 30 Jun 2016
Q1 2016 297 +56.9 +23.7% 31 Mar 2016
Q4 2015 269 +52.2 +24.1% 31 Dec 2015
Q3 2015 287 +161 +127% 30 Sep 2015
Q2 2015 301 +224 +289% 30 Jun 2015
Q1 2015 240 +187 +353% 31 Mar 2015
Q4 2014 217 +184 +556% 31 Dec 2014
Q3 2014 126 +93.1 +279% 30 Sep 2014
Q2 2014 77.5 +42.2 +120% 30 Jun 2014
Q1 2014 53 +18.6 +54% 31 Mar 2014
Q4 2013 33 +2.58 +8.48% 31 Dec 2013
Q3 2013 33.3 +2.32 +7.49% 30 Sep 2013
Q2 2013 35.2 -0.09 -0.26% 30 Jun 2013
Q1 2013 34.4 -8.02 -18.9% 31 Mar 2013
Q4 2012 30.4 -20.6 -40.4% 31 Dec 2012
Q3 2012 31 30 Sep 2012
Q2 2012 35.3 30 Jun 2012
Q1 2012 42.4 31 Mar 2012
Q4 2011 51.1 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.